





Does AI Guarantee ROI?
The buzz surrounding AI's role in healthcare is undeniable. Yet, amidst these discussions, a key question remains: Where should AI be harnessed to truly optimize return-on-investment (ROI)?






Enhancing Patient Experiences with Data-Driven Insights
In the modern healthcare landscape, the importance of leveraging data-driven insights to enhance patient experiences cannot be overstated. Pharmaceutical companies need to connect with patients because it can bring about big changes in how healthcare is provided






Evaluating Health Economic Outcomes of DTx
2023 has been a challenging year for DTx, and now, more than ever, it has become increasingly important for DTx solutions to showcase robust health economics to secure stakeholder buy-in.







Pharma's Role in Remote Patient Monitoring in Oncology
Remote patient monitoring (RPM) is a key component of digital health, especially in the field of oncology.







MedTech: New Revenue Opportunities with Digital, Data and Connectivity
Are you struggling to establish digital as a cornerstone of your revenue generation strategy? Then this session is for you!







Business Models for Virtual Care Delivery
In a market progressively gravitating toward decentralised, consumer-centric healthcare delivery, the business models we use for virtual care must adapt and grow too. Different approaches are constantly emerging, and there’s no one-size-fits-all solution.







Digital Biomarkers in Neurology: Early Diagnosis & Disease Management
Neurological disorders, given their intricate nature and often elusive markers, pose a significant challenge to neurologists striving for early diagnosis and effective treatment.







Sustainable Business Models for Remote Patient Monitoring Solutions







Pharma 3.0: A framework for doing digital health better
Digital health’s interaction with pharma is evolving; it has to evolve. Join this expert led discussion where we will deep dive into the future of Pharma. Seats are limited so apply now to secure your place.







Upskilling Medical Affairs for Digital Health
In an era of digital transformation, the way in which we care and treat patients is fundamentally being altered.







Evidence Generation: What payers are looking for
Establishing the effectiveness of your solutions and securing reimbursement can be a daunting task. In the evolving reimbursement landscape, presenting a compelling value proposition and robust evidence base becomes crucial.







Designing Agile and Responsive Pharma Patient Experience to Improve Drug Adherence
As the landscape of pharmaceuticals evolves, understanding and adapting to emerging, tech-enabled patient journeys is critical. Improving these journeys is central to enriching patient experiences and, by extension, improving treatment adherence.







Balancing AI and Human Involvement in Digital Health
As artificial intelligence gains traction in healthcare, the industry finds itself at a crossroads, torn between the anticipation of AI's vast potential and the concerns surrounding ethical and patient safety issues. Join HealthXL as we deep dive into this session, register now to secure your place.







Quantifying the Benefits of Digital Biomarkers in Pharma
This session is an invite-only meeting. To find out more please contact us.
With the rise of connected sensor technologies, and wearable devices that can offer objective, continuous patient measurements, healthcare stakeholders are presented with a wealth of opportunities to innovate how we measure health.







Mental Health: Getting your D2C Solution to be the Consumer's Top Pick
Compared to other therapeutic areas, mental health presents itself as an area ripe for sustainable direct-to-consumer (D2C) business models. Join us as we delve into these trends within the digital mental health landscape, and explore effective strategies when going down the D2C route.







Are open source DTx solutions the path to scalability?
Since the inception of medicine, practitioners have been sharing observations and best practices.







How Can Pharma Companies Get the Most Out of a Platform Approach?
With new platform technologies emerging, there is an opportunity to elevate pharma’s digital initiatives to a more flexible and globally compliant framework that can scale across multiple markets and therapy areas. Join your peers in this interactive discussion. Seats are limited so apply now to secure your place.







From Algorithms to Assets: Monetising Real-World Patient Data with AI
Artificial Intelligence (AI) is disrupting traditional business models by extracting deeper insights from diverse data sets. Join HealthXL in this meeting to deep dive into this topic with your peers working in this space. Seats are limited so apply now to secure your place.







Adherence in the U.S: Are We Making the Right Assessments and How Can Improvements Be Made?
The patient experience is becoming increasingly recognised as a major component of chronic condition treatment delivery. Join us in this roundtable discussion led by Health Beacon where we will deep dive into this topic. Spaces are limited so apply now to secure your seat.







Adoption Of Digital Mental Health Solutions: How Cultural Differences Affect Uptake
Cultural context significantly influences perceptions and approaches to mental health conditions.







Advancing Digital Oncology Through Public-Private Partnerships
We have made remarkable progress in oncology treatments, yet, many patients are still grappling with basic, and often preventable, barriers to care.
.jpeg)






Partnership Roadmap with Life Sciences Companies for Digital Health in Cardiometabolic Diseases
Life sciences companies and digital health startups are teaming up to improve outcomes and reduce the burden of cardiometabolic diseases. Join HealthXL in this session to deep dive into this topic. Apply now to secure your place.







Patients as Consumers: Why Pharma Must Deliver a Convenient, Connected Patient Experience
The consumerisation of healthcare has given rise to a new generation of patient with heightened expectations for seamless and personalised experiences.







The New Role of Medical Affairs: Enabling Digital HCP Engagement and Scientific Communication
Digital health is changing the Medical Affairs (MA) function; the introduction of connected technology alongside drugs provides MA with new methods of reaching patients and their physicians.







Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this exclusive roundtable where we will discuss the highlights from our recent HealthXL Pharma 3.0 report and how pharma can do digital health better in the next few years.






Adherence in the U.S: Are We Making the Right Assessments and How Can Improvements Be Made?
The patient experience is becoming increasingly recognised as a major component of chronic condition treatment delivery. Join us in this roundtable discussion led by Health Beacon where we will deep dive into this topic. Spaces are limited so apply now to secure your seat.







Digital Assessments in Remote Trials: Exploring Pharma's Implementation Strategies
The integration of digital assessments, digital-enabled measures as well as novel digital biomarkers, into clinical trials has created a new era of patient-centric and decentralised trials. Apply now to join your peers in this discussion. Seats are limited so apply now to secure your place.







Beyond Point Solutions: Will an Ecosystem Approach Unlock Digital Health’s Full Potential for Pharma?
Point solutions have been the norm for pharma to date. Brands create an app in isolation, often duplicating underlying infrastructure already created for other siloed products elsewhere in the company. Join your peers in this discussion led by Appnovation. Spaces are limited so apply now to secure your place.







AI-driven Innovations for Clinical Decision Making
Artificial intelligence (AI) is beginning to seep into all aspects of healthcare - but its role as a tool for clinical decision making is still under scrutiny. Apply now to join your peers in this discussion. Spaces are limited so register now to secure your place.






Preparing Investment Rounds: Best Practices for DTx Startups
In the face of macroeconomic challenges and a tightening financial landscape, DTx startups are experiencing an intensified competition for investment. Join HealthXl in this peer led discussion to deep dive into this topic. Seats are limited so apply now to secure your place.







Innovation showcase: Remote Patient Monitoring (RPM) for Cardiovascular Diseases
In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Seats are limited to 3 Pharma/Medtech/VC and 3 digital health companies so we can pair you 1-2-1. Apply now to book your place!






Existing and New Distribution Channels for DTx
Digital therapeutics (DTx) are yet to show success at scale with traditional salesforce distribution channels. Apply now to discuss this further with your peers working in this space.







Remote Patient Monitoring to Improve Surgical Workflows
Remote patient monitoring (RPM) technologies can benefit the entire surgical workflow, by allowing preoperative and postoperative monitoring that improves patient experience and reduces the overall cost of care. Apply now to secure your place as we deep dive into this topic.







Digital Health to Overcome the Siloed Care Pathways in Immunology
Digital health care pathways in immunology can become siloed due to the fragmentation of healthcare services and the lack of interoperability among healthcare systems and providers. Apply now to join this session and deep dive into this topic with your peers working in this space.







Integrating Oncology Digital Health into Clinical Practices
The benefits of digital technologies in oncology are undeniable; however, effectively demonstrating their value to end users is pivotal for the success of these products. Apply now to join your peers in this interactive discussion. Spaces are limited so apply now to secure your seat.







Empowering Primary Care with Digital Health for Equitable Mental Wellbeing
The primary care model has become a key focus in mental health in the US due to a shortage of therapists and specialists. Join HealthXL in this meeting as we deep dive into this topic. Seats are limited so apply now to secure your place.







GPT for Life Sciences - What Does The Future Hold?







What does ‘a good DTx’ look like?
When it comes to digital therapeutics (DTx), there are many permutations, and what distinguishes a ‘good DTx’ can be difficult to define in a space that is constantly evolving. Apply now to join HealthXL in this session where we will deep dive into this topic. Apply now to secure your space, seats are limited.







Role Of Digital Health Across Brand Life Cycle In Pharma
Throughout each phase of a drug's life cycle, it is crucial to optimise both clinical and product value: from pre-launch and launch, to growth, maturity, and eventual decline. Apply now to join your peers to discuss this topic further.







The Power of Mental Health Improvement Tools: Showing Pharma Their Potential Across All Therapeutic Areas
While pharma is beginning to recognise the power of digital mental health tools, it is still challenging to get the true value recognition for these solutions. Join your peers to deep dive into this topic. Seats are limited so apply now to secure your place.







How to Structure a Deal Between DTx and Pharma Companies?
Structuring a deal between pharmaceutical companies and digital therapeutics (DTx) companies can be complex, and the specifics will depend on various factors, including the therapeutic area to which the deal pertains, market size, and development stage of the DTx solution. Apply now to join your peers in this discussion.







Pharma Brand Strategies for Driving HCP Engagement and Adoption with Sponsored DTx Solutions
In the aftermath of COVID-19, the patient journey has undergone considerable changes as digital tools and technologies have become increasingly integrated into the journey. Seats are limited. Apply now to join your peers in this discussion.







The Role of Medical Affairs in Advancing Digital Health
Medical affairs (MA) teams play a critical role in communicating with the wider medical fraternity and commercially supporting pharmacologics. Join us in this session where we will deep dive into this topic. Seats are limited so apply now to secure your place.
.jpg)






Beyond the Provider: Alternative Paths to Adoption of Oncology Digital Health Solutions
Engaging healthcare providers is crucial to drive patient adoption of digital health solutions. Apply now to join HealthXL in this peer to peer discussion.







Hybrid Care: How Could the Players in the Ecosystem Work Together to Make It Impactful?
Whilst the Covid-19 outbreak created strong incentives to go digital, it also demonstrated the value of in-person interactions. Apply now to join this session and dive deeper into this topic with your peers working in this space.







Are Hospitals the Right Partner for Digital Health Companies in Oncology?
Digital health in oncology is still a very raw and undefined practice with companies still searching for a best approach to put these solutions into the patients' hands. Join this peer-to-peer conversation to deep dive into this discussion.







Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss the highlights from the report and how pharma can do digital health better in the next few years.






The Potential of OTC DTx Solutions
Curious about what is in store for the future of OTC DTx solutions? Join in the conversation with our expert panel to find out! Spaces are limited so apply now to secure your place.







Embracing Digital Health for Hospital at Home Solutions
By reducing hospital admissions, and in-person care services, digital hospital at home solutions are emerging as cost-effective services for health systems. Join HealthXL in this discussion. Apply now to secure your place.







Panel Discussion: Patient Engagement Through a Digital Health Front Door
The digital front door is a powerful approach to improve patient engagement and care delivery, but it requires a patient-centric and holistic approach to be successful. Apply now to join HealthXL in this panel discussion with leaders working in this space.







Data Monetisation for MedTech Companies
With the proliferation of digital health solutions developed and commercialised by MedTech firms, the volume of healthcare data they generate is expanding rapidly. Apply now to join your peers and discuss this topic further.







Pharmacies in the US as a Distribution Model for DTx
The large pharmacy chains model in the US presents pharmacies as a promising distribution channel for Digital Therapeutics (DTx). Apply now to join this discussion with your peers working in this space.







Innovation Showcase: Digital Biomarkers in CNS and Cognition Assessment
In this innovation showcase, 3 Digital Biomarkers companies working on CNS and cognition assessment will meet 121 with 3 Pharma/Medtech/Investors to discuss mutual challenges when building successful collaborations. Seats are limited to 3 Pharma/Medtech/Investors and 3 Digital Biomarkers companies so we can pair you 1-2-1. Apply now to book your place!






Pharma 3.0: Doing Digital Health Better
Digital health’s interaction with pharma is evolving; it has to evolve. Join us in this roundtable to discuss how pharma can do digital health better in the next few years.






Scalable Market Access Strategies Targeting Payers in the US
Despite DTx gaining traction in terms of investment, adoption still remains a challenge, and DTx companies struggle to secure reimbursement. Apply now to join your peers as we deep dive into this topic.







Patient Engagement Metrics in Digital Health for Oncology
Measuring patient engagement with digital health solutions is crucial to ensure the digital intervention is impactful and helps improve patient outcomes. Join this discussion to dive deeper into this topic with your peers working in this space. Seats are limited to apply now to secure your place.







Extended-Reality (XR) Solutions in Mental Health and Substance Use Disorders
Extended Reality (XR) is a powerful technology that can be used anywhere, at any time. Join HealthXL in this meeting as we discuss this topic further. Seats are limited so apply now to secure your place.







Beyond Pharma: Finding the Best Commercial Partner for Digital Health in Oncology
Whilst digital health startups in oncology have tried to build prosperous partnerships with pharma, there are no outstanding results yet, and it has proven hard to make it work. Seats are limited for this event so apply now to deep dive into this topic with your peers.







Innovation Showcase: Digital Health Solutions in Oncology
In this innovation showcase, 3 Digital Health companies in Oncology will meet 121 with 3 Pharma/Medtech/Investors/Healthcare Providers, to discuss mutual challenges when building successful collaborations. Apply now to join this session as seats are limited.






Standards for Robust Evidence from Digital Health in Oncology
Due to the lack of industry-wide evidence frameworks for digital health solutions in oncology, regulators' and payers' requirements are usually the same as drugs. Join HealthXL in this meeting to deep dive into this topic.







Digital Biomarkers for Mental Health Evaluation and Management
Unlike other therapeutic areas, mental health evaluation and management can be a bit of an art, and at times relies on subjectivity in the outcomes analysis. Join this meeting to discuss this topic further with others working in this space. Places are limited so apply now to avoid disappointment.







The Role of the Consumer Experience in DTx
As technology advances in all sectors (e.g. fintech, entertainment, etc), consumer behaviour changes and the expectations on user experience are higher than before. Apply now to secure your place in this meeting where you will dive deeper into this topic with your peers.







Business Opportunities for Digital Health in Autoimmune Conditions: Upcoming Blockbuster Drugs
Millions of people worldwide suffer from autoimmune conditions such as rheumatoid arthritis (RA), psoriasis, lupus, Crohn's disease, multiple sclerosis, atopic dermatitis, to name a few. Join this meeting to deep dive into this topic in the Immunology Meeting Series. Seats are limited so apply now to secure your place.







Product Differentiation for Digital Health Solutions in the Cardiometabolic Disease Area
In the past few years, digital health solutions have proven to be helpful in preventing and managing cardiometabolic diseases remotely, leading to better health outcomes and less hospitalizations, emergency visits, and in-office visits.







Masterclass: How to Move from DTx Point Solutions to Platforms?
Why is now the right time to move from DTx point solutions to platforms? How to bring this to life? Join this meeting to discuss this topic further with your peers. Apply now to secure your seat.







Healthcare Provider Adoption of Digital Solutions in Mental Health
How can we help healthcare providers and health systems sift through the universe of digital solutions in mental health? How can digital health companies engage providers? Join this meeting to deep dive into this topic with your peers. Spaces are limited so apply now to secure your place.







Digital Health for Trigger Management in Autoimmune Conditions
It can be hard for HCPs to provide precise medical decisions in autoimmune conditions due to the patient variability and the trigger events not being fully understood. Join other senior leaders in this meeting to discuss this topic further.







Increase DTx Market Access and Adoption via Precision Patient Engagement
Market access and adoption are huge challenges in the DTx and Pharma/Life Sciences industry. Apply now to deep dive into this topic with your peers working in this space.







How Can Virtual Care Solutions Help Health Systems Bounce Back After Covid?
Health systems have been shocked in a way that has never been seen before with the COVID-19 pandemic. Join HealthXL in this meeting to discuss this topic with your peers working in this space.







Revenue Generation in Pharma-DTx Partnerships
Many pharma companies have explored partnerships with DTx companies in the last few years, seeking for innovative technologies that add value to their products and services. Apply now to secure your place in this Digital Health meeting.
.jpg)






The Intersection between DTx and Human Coaching in Mental Health
The connection between DTx and human coaching in mental health can weave together a more precise, personalized, and connected care experience. Apply now to join this meeting to discuss this topic further with your peers.







Innovation Showcase: Remote Patient Monitoring Programs in Oncology
In this innovation showcase, Pharma, Medtech, and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Spaces are limited so apply now to secure your place.







Innovative Distribution Strategies for DTx
Currently, there is no one-size-fits-all strategy for DTx distribution. Join HealthXL in this meeting to discuss this topic further with your peers working in this space.






Driving Adoption for non-Prescription DTx
Without adoption, even the best DTx solution will have no impact. Apply now to join this meeting and discuss this topic further with your peers working in this space







DTx-Drug Combination Therapy: What Should the Trial Look Like?
DTx-Drug combinations can improve the treatment value, thus leading to better patient outcomes. Join HealthXL in this session to discuss this topic with thought leaders in this space.







Roadmap Execution in a Pharma-DTx Partnership
While the number of partnerships between DTx and Pharma have grown in the past years, we haven’t seen big successes yet, and part of that could be due to bad roadmap definition and its execution. Join your peers in this meeting to discuss this topic further







Building Incentive Models for Digital Health in Neurodegenerative Diseases
In Neurodegenerative Diseases, aging is a risk factor and as the older populations grow, its prevalence increases, leading to an enormous burden on healthcare systems. Join this meeting to deep dive into this topic with other senior leaders in this field.







Adoption Beyond Reimbursement for Digital Health in Oncology
Are you struggling to get patients and healthcare professionals (HCPs) to adopt your digital health product? Join this meeting to deep dive into this topic with your peers working in this space.







Integrating Oncology Digital Health with Health Systems Workflows
Oncology services have changed in recent years from the way cancer is diagnosed to how treatment is being delivered. Join other senior leaders in this session to deep dive into this topic.







Big Tech and Digital Health
There is no question that Big Tech has the capability to disrupt healthcare, though the complexity of healthcare ecosystems is not making it easy for these companies. Join this meeting to dive deeper into this topic and discuss how Big Tech is getting into digital health.







Building a Value Proposition that Addresses Payers Pain Points
Many DTx companies target payers to get reimbursed, but very few vendors get what they are looking for. Join this meeting to deep dive into this topic with other senior leaders in this area.







Digital Health for the Prediction of Cardiovascular Events
Cardiovascular diseases (CVD) have been at the forefront of digital health innovations. Join HealthXL in this meeting where we will focus on the use of digital health tools for the prediction of cardiovascular events.







Physician Adoption of Prescription DTx
Physician adoption is one of the keys to unlocking the revenues expected from DTx solutions. Join HealthXL in this meeting to discuss this topic with other senior leaders in this field.







Partnerships between Oncology Digital Health and Life Sciences Companies
In a complex disease area like oncology, treatments usually cause adverse effects that compromise patients' quality of life. Join this session to discuss this topic further with your peers working in this field.







How to Sell DTx to Life Sciences Companies?
Over the last few years, partnerships between digital therapeutics (DTx) and Life Sciences companies have grown exponentially. Join HealthXL in this meeting to discuss this topic with thought leaders in this area.







Outcome Measures in Oncology Digital Health Interventions: What and How to Measure?
Digital health solutions can track a huge amount of data points, but tracking too many different measures can make you lose focus. Join HealthXL in this meeting to discuss this with other thought leaders working in this area.







Innovation Showcase: Digital Health Solutions for Decentralized Clinical Trials
In this innovation showcase, Pharma, Medtech and VC will meet 1-2-1 with potential Digital Health partners to discuss mutual challenges they face when building successful collaborations. Apply now to book your place in this bilateral discussion.







Success Metrics of Patient Engagement with DTx Solutions
In a world where customers are used to excellent user experience (e.g. Google, Amazon, Apple, etc.), DTx companies need to meet customers' expectations. Join other senior leaders in this session to discuss what the success metrics of patient engagement are for DTx solutions.







Combined Label Claims for Drug + DTx Combinations
As more DTx-drug combinations emerge, regulation is becoming increasingly important. Join HealthXL in this meeting to dive deeper into this topic.







Partner Search and Selection for Digital Health Companies in Mental Health
Digital solutions have great potential in mental health, improving care access, symptom tracking, and treatment personalization. Join HealthXL in this meeting to discuss this topic further with your peers working in this area.







Executive 1-2-1 with the HealthXL Digital Health Community
Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!







What are the Best Business Models for DTx in the US?
What are the best models for DTx in the US in this new reality? How will the business models change in the future? Join us in a peer-to-peer conversation where we will discuss these questions and more!







Are Pharma Partnerships the Wrong Strategy for DTx Companies?
While the digital therapeutics (DTx) market is increasingly growing, it is still small compared to large players in the healthcare industry such as pharma. Join HealthXL in this peer-to-peer discussion to deep dive into this topic.







What Will the Best Business Models Be for Virtual Care in Diabetes?
Join this meeting to take a deep dive into what the best business models will be in the next few years for virtual care companies in the diabetes space.







If DTx Companies Operated like Pharma, What Would We Have?
Pharma companies are huge corporations with complex operations to ensure the quality of their products and services. Join HealthXL in this meeting to deep dive into this topic with others working in this space.







Pharma Partnerships with Virtual Care Companies
The accelerated growth of the virtual care industry since the pandemic has opened many opportunities for virtual care companies. Join HealthXL in this meeting to dive deeper into this topic and discuss further with your peers working in this space.







Are DTx a Service or a Product?
Digital therapeutics (DTx) and drugs are very different care solutions. However, DTx are often compared to traditional pharmaceutical products because the terminology and definitions are unclear. Join this meeting to discuss this topic further with your peers.







Do’s and Don’ts when Seeking Partnerships for Digital Health in Oncology
Most digital health companies in oncology will struggle to get their products in the market on their own. Join HealthXL in this meeting to discuss the do's and don'ts when seeking partnerships for digital health companies in oncology.







Executive 1-2-1 with the HealthXL Digital Health Community
Do you want to network with other innovators and leaders in digital health? Are you looking to identify potential partners? Join us for the new HealthXL style of virtual speed networking and meet other members working in this space!







New Distribution Channels for DTx
Are you trying to figure out what is the best distribution channel for your digital therapeutics (DTx) solution? Join this meeting to discuss this topic further with your peers working in this space.







Sustainable Business Models for Digital Health in Neurology
Digital health companies can take different routes to market, however, finding the one that is sustainable and scalable in the long term, is not an easy task. Join this meeting to discuss this topic further with others working in this space.







Evidence Requirements for DTx vs Drugs
Are you targeting payers as part of your market access strategy? What do you need to know about their evidence requirements for DTx? Join HealthXL in this meeting to discuss this topic further with your peers working in this space.







Seeking Capital for DTx
Are you a digital therapeutics (DTx) start-up seeking capital? How can companies get attention from investors in an increasingly competitive industry? Join HealthXL in this meeting to discuss this topic further with others working in this space.
